Dementia: Challenges and promising developments

The Lancet Neurology

Volumn 10, Issue 1, 2011, Pages 7-9

  Ballard, Clive ^a   Corbett, Anne ^b   Jones, Emma L ^a  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b ALZHEIMER'S SOCIETY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID; APOLIPOPROTEIN E4; CLUSTERIN; CYANOCOBALAMIN; D DIMER; DIMEBON; FOLIC ACID; HOMOCYSTEINE; PLACEBO; PROTHROMBIN; PYRIDOXINE; SERTRALINE;

ADL DISABILITY; AGITATION; ALZHEIMER DISEASE; BRAIN ATROPHY; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; DEPRESSION; DISEASE ASSOCIATION; DRUG EFFICACY; DRUG MEGADOSE; GASTROINTESTINAL SYMPTOM; HUMAN; MILD COGNITIVE IMPAIRMENT; NERVE DEGENERATION; NEUROPATHOLOGY; NOTE; PRIORITY JOURNAL; PSYCHOSIS; RESPIRATORY TRACT DISEASE; TREATMENT OUTCOME;

COGNITION DISORDERS; DATA COLLECTION; DEMENTIA; HUMANS; MAGNETIC RESONANCE IMAGING; VASCULAR DISEASES; VITAMINS;

EID: 78650027983     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70304-5     Document Type: Note

References (10)

1. Dubois B, Feldman HH, Jacova C, et al. Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria. Lancet Neurol 2007, 6:734-746.
2. Thambisetty M, Simmons A, Velayudhan L, et al. Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease. Arch Gen Psych 2010, 67:739-748.
3. Harold D, Abraham R, Hollingworth P, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nat Genet 2009, 41:1088-1093.
4. Stott DJ, Robertson M, Rumley A, et al. Activation of hemostasis and decline in cognitive function in older people. Arterioscler Thromb Vasc Biol 2010, 30:605-611.
5. Dimebon disappoints in phase 3 trial Alzheimer Research Forums, (accessed Nov 24, 2010). http://www.alzforum.org/new/detail.Asp?id=2387.
6. Smith AD, Smith SM, de Jager CA, et al. Homocysteine-lowering by B vitamins slows the rate of accelerated brain atrophy in mild cognitive impairment: a randomized controlled trial. PLoS ONE 2010, 5:e12244.
7. Ballard CG, Gauthier S, Cummings JL, et al. Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009, 5:245-255.
8. Rosenberg PB, Drye LT, Martin BK, et al. Sertraline for the treatment of depression in Alzheimer disease. Am J Geriatr Psychiatry 2010, 18:136-145. DIADS-2 Research Group.
9. Ritchie K, Carrière I, Ritchie CW, Berr C, Artero S, Ancelin ML Designing prevention programmes to reduce incidence of dementia: prospective cohort study of modifiable risk factors. BMJ 2010, 341:3885.
10. Owen AM, Hampshire A, Grahn JA, et al. Putting brain training to the test. Nature 2010, 465:775-778.